Growth Metrics

Travere Therapeutics (TVTX) Long-Term Deferred Tax (2017)

Travere Therapeutics (TVTX) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $4.8 million as the latest value for Q3 2017.